The company is developing lipid nanoparticles (LNPs) and messenger RNA (mRNA) to address various diseases. Its therapy focuses on reducing harmful cholesterol inside cells, not just in the blood.
5 Likes
The company is developing lipid nanoparticles (LNPs) and messenger RNA (mRNA) to address various diseases. Its therapy focuses on reducing harmful cholesterol inside cells, not just in the blood.